Literature DB >> 31742530

Middle East Respiratory Syndrome Coronavirus Seropositivity in Camel Handlers and Their Families, Pakistan.

Jian Zheng, Sohail Hassan, Abdulaziz N Alagaili, Abeer N Alshukairi, Nabil M S Amor, Nadia Mukhtar, Iqra Maleeha Nazeer, Zarfishan Tahir, Nadeem Akhter, Stanley Perlman, Tahir Yaqub.   

Abstract

A high percentage of camel handlers in Saudi Arabia are seropositive for Middle East respiratory syndrome coronavirus. We found that 12/100 camel handlers and their family members in Pakistan, a country with extensive camel MERS-CoV infection, were seropositive, indicating that MERS-CoV infection of these populations extends beyond the Arabian Peninsula.

Entities:  

Keywords:  MERS-CoV; Middle East respiratory syndrome; Pakistan; camel handlers; coronavirus; pneumonia; respiratory infections; viruses; zoonoses

Mesh:

Year:  2019        PMID: 31742530      PMCID: PMC6874235          DOI: 10.3201/eid2512.191169

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), identified in 2012, causes a highly lethal pneumonia with a 34.5% mortality rate (https://www.who.int/emergencies/mers-cov). As of July 31, 2019, a total of 2,458 cases and 848 deaths have been reported to the World Health Organization, with all cases in the Middle East or in travelers from this region or their contacts (). MERS cases fall into 2 categories, primary and secondary. Secondary cases, which result most commonly from human-to-human transmission in hospitals, were most prominent during the early years of the outbreak. However, as stringent infection control measures have been followed more closely, a greater proportion of cases are classified as primary. Camels are believed to be the zoonotic source for primary infections, but a large proportion of patients describe no camel contact, raising the question of how they acquired the disease (). To determine the source of the infection, several studies have focused on a potential role in transmission for camel handlers. These reports indicate that the percentage of MERS-CoV–immune camel handlers is much greater than in the general population of Saudi Arabia, the country with the largest number of MERS cases. These studies have reported that 3%–67% of camel handlers in this country are MERS-CoV exposed, compared with 0.15% of the general population (–). In Saudi Arabia, much of camel farming is labor intensive, and many camel owners hire camel handlers, generally from outside of the country, to tend to them (). To determine the generalizability of these observations, we tested blood samples from 100 camel handlers and their families in the Cholistan desert in Punjab, Pakistan, a country with no reported human MERS ().

The Study

We chose Cholistan as the study site because it is the most important region of Pakistan for the camel industry, and handlers and their families are in close contact with dromedaries. We engaged study participants in the Bahawalnagar and Bahawalpur districts, located in southern Punjab Province, Pakistan. The Institutional Ethical Review Board (IERB) of the Institute of Public Health, Government of Punjab, Lahore, Pakistan, approved the study. We obtained written informed consent from all study participants. Camel handlers in Cholistan differ from those in Saudi Arabia in that they own their camels, along with cows, goats, and sheep, and they and their families take care of these animals. Both men and women are responsible for grazing, feeding, milking, and waste disposal. In addition, they live in close proximity to camels and share similar water sources (–). Camel handlers in Cholistan are either nomadic, seminomadic, or sedentary, with varying degrees of exposure to camels. Nomads live with their camels in the desert and migrate throughout Cholistan, whereas seminomads tend to live at a base camp and migrate depending on availability of fodder and water. Nomadic camel handlers and their families have the highest exposure to camels, whereas sedentary ones have the least exposure. During 2017–2018, we obtained blood samples from 100 participants from nomadic, seminomadic, and sedentary populations. The age range was 8–76 years (average 30.1 years). We obtained demographic and clinical information at sampling by written questionnaire, including participant age, lifestyle (nomadic, seminomadic, sedentary), role in family (husband, wife, child, etc.), underlying medical conditions, numbers of camels owned, history of tobacco use (smoking or chewing), and consumption of camel products (milk) (Table 1; Appendix Table). We transported samples to the microbiology department at the University of Veterinary and Animal Sciences (Lahore, Punjab, Pakistan). We prepared serum samples, stored them at −80°C, and shipped them to the University of Iowa (Iowa City, Iowa, USA) for analysis.
Table 1

Characteristics of participants in study of Middle East respiratory syndrome coronavirus seropositivity in camel handlers and their families, Pakistan

CharacteristicNo. (%) participants
Lifestyle
Sedentary10 (10)
Seminomadic64 (64)
Nomadic
26 (26)
Concurrent conditions21 (21)
Consumption of unpasteurized camel milk 98 (98)
Tobacco use38 (38)
We tested all the samples for MERS-CoV–specific antibodies by ELISA and 50% reduction plaque-reduction neutralization test (PRNT50). Of 91 participants examined by a commercially available ELISA, 49 were positive for MERS-CoV–specific antibody. Twelve had PRNT50 titers >1:20 and were considered positive; of these, 5 were also positive by ELISA. In addition, 10/12 were positive by immunofluorescence assay. Of the 12 PRNT50-positive participants, 3 were women and 1 was an 8-year-old child (Table 2).
Table 2

Characteristics of camel handlers and their families positive for Middle East respiratory syndrome coronavirus in study in Pakistan*

Patient no.Family no.Age, y/exCamel contact†SmokingConcurrent conditionsLifestylePRNT50ELISA result/ value‡IFA result/§
SH94F220/MDirect/dailyYesNoneNomadic211–/0.78 +/1:80
SH85F221/MDirect/dailyYesNoneNomadic32+/1.51+/1:40
SH100F18/MDirect/dailyNoNoneNomadic72–/0.64+/1:40
SH71F935/FIndirectNoHPT, renal and respiratory diseaseSeminomadic33Borderline/​.99+/1:20
SH74F940/FIndirectNoHPTSeminomadic40+/2.18+/1:80
SH63F1335/FDirect/monthlyNoNoneSeminomadic27Borderline/​0.92+/1:10
SH57F1420/MDirectNoNoneSeminomadic51+/3.11+/1:80
SH58F1628/MDirectYesNoneSeminomadic68+/1.74+/1:160
SH21None17/MDirect/seasonalYesNoneSeminomadic80–/0.36–/<1:10
SH65None20/MD/dailyNoNoneSeminomadic65+/1.13+/1:80
SH43None34/MDirectNoNoneSedentary1,600–/0.76+/1:160
SH44None40/MDirectYesNoneSedentary89–/0.48–/<1:10

*All 12 patients tested positive by PRNT50. IFA, immunofluorescence assay; HPT, hypertension; PRNT50, 50% reduction plaque reduction neutralization assay.
†Direct indicates camel herders with direct camel contact but extent of exposure is not known; direct/daily, camel herders with daily direct camel contact; direct/monthly, camel herders with monthly direct camel contact; direct/seasonal, camel herders with seasonal direct camel contact; indirect, family members of camel herders.
‡Positive result is >1.1; borderline, 0.8–1.1; negative, <0.8, as defined by the test manufacturer.
§Negative test result is <1:10, as defined by the test manufacturer.

*All 12 patients tested positive by PRNT50. IFA, immunofluorescence assay; HPT, hypertension; PRNT50, 50% reduction plaque reduction neutralization assay.
†Direct indicates camel herders with direct camel contact but extent of exposure is not known; direct/daily, camel herders with daily direct camel contact; direct/monthly, camel herders with monthly direct camel contact; direct/seasonal, camel herders with seasonal direct camel contact; indirect, family members of camel herders.
‡Positive result is >1.1; borderline, 0.8–1.1; negative, <0.8, as defined by the test manufacturer.
§Negative test result is <1:10, as defined by the test manufacturer. All but 2 of the study participants were exposed to camels. There was no significant correlation (p>0.5) between MERS-CoV seropositivity and lifestyle, presence of concurrent conditions, drinking unpasteurized camel milk, or tobacco use, with the caveat that the sample size was small.

Conclusions

In general, nomads had the most and sedentary populations had the least camel contact, although nearly all family members were exposed to and took care of camels. Of 100 participants, we identified 12 who were MERS-CoV seropositive, as measured by the presence of PRNT50 antibody. Of note, several PRNT50-positive samples were negative by ELISA, but most were positive by immunofluorescence assay. This lack of concordance between ELISA and PRNT50 titers was observed previously (,) and may reflect lower sensitivity of the commercial ELISA kit (). Other coronaviruses circulate in camel populations (), and it is conceivable that the high rate of ELISA seropositivity resulted from immune responses to other, possibly MERS-like, coronaviruses present in Pakistan. Thus, it will be important to assess camel (and human) populations for other coronaviruses that might elicit a cross-reactive response. The mechanism of MERS-CoV transmission from camels to humans in Pakistan is not established, but most camel handlers and their families drink fresh camel milk, obtained after young camels have finished nursing. Juvenile camels demonstrate the highest rate of seroconversion and of MERS-CoV positivity (,), so it is possible that drinking fresh milk is a source of infection. In this region of Pakistan, camel handlers and their families also share water sources with camels, which probably contributes to virus transmission. Zohaib et al. identified a 75.6% MERS seroprevalence in camels throughout Pakistan, but 0% seropositivity in humans, including some with camel contact (). Medical services in Cholistan and adjacent areas are limited, making MERS diagnosis and transmission studies difficult. Our findings show a need for additional studies to confirm the absence of clinically apparent MERS in this region and to determine whether epidemiologic, technical, or other factors caused differences in seropositivity between our study and that of Zohaib et al. Our study, by demonstrating a low but detectable rate of MERS-CoV seropositivity in camel handlers and their families, indicates that this population could contribute to MERS-CoV transmission to the broader community in Pakistan. We previously showed that measurement of T cell responses identified additional MERS-CoV–immune persons (,), suggesting that our results may underestimate the prevalence of MERS-CoV infection. Our results also illustrate the importance of educating camel herders and their families about proper infection control measures, including handwashing, to diminish the likelihood of MERS-CoV transmission.

Appendix

Additional information about Middle East respiratory syndrome coronavirus seropositivity in camel handlers and their families, Pakistan.
  11 in total

1.  Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses.

Authors:  Jingxian Zhao; Abeer N Alshukairi; Salim A Baharoon; Waleed A Ahmed; Ahmad A Bokhari; Atef M Nehdi; Laila A Layqah; Mohammed G Alghamdi; Manal M Al Gethamy; Ashraf M Dada; Imran Khalid; Mohamad Boujelal; Sameera M Al Johani; Leatrice Vogel; Kanta Subbarao; Ashutosh Mangalam; Chaorong Wu; Patrick Ten Eyck; Stanley Perlman; Jincun Zhao
Journal:  Sci Immunol       Date:  2017-08-04

2.  Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia.

Authors:  Jamal S M Sabir; Tommy T-Y Lam; Mohamed M M Ahmed; Lifeng Li; Yongyi Shen; Salah E M Abo-Aba; Muhammd I Qureshi; Mohamed Abu-Zeid; Yu Zhang; Mohammad A Khiyami; Njud S Alharbi; Nahid H Hajrah; Meshaal J Sabir; Mohammed H Z Mutwakil; Saleh A Kabli; Faten A S Alsulaimany; Abdullah Y Obaid; Boping Zhou; David K Smith; Edward C Holmes; Huachen Zhu; Yi Guan
Journal:  Science       Date:  2015-12-17       Impact factor: 47.728

3.  Countrywide Survey for MERS-Coronavirus Antibodies in Dromedaries and Humans in Pakistan.

Authors:  Ali Zohaib; Muhammad Saqib; Muhammad Ammar Athar; Jing Chen; Awais-Ur-Rahman Sial; Saeed Khan; Zeeshan Taj; Halima Sadia; Usman Tahir; Muhammad Haleem Tayyab; Muhammad Asif Qureshi; Muhammad Khalid Mansoor; Muhammad Ahsan Naeem; Bing-Jie Hu; Bilal Ahmed Khan; Ikram Din Ujjan; Bei Li; Wei Zhang; Yun Luo; Yan Zhu; Cecilia Waruhiu; Iahtasham Khan; Xing-Lou Yang; Muhammad Sohail Sajid; Victor Max Corman; Bing Yan; Zheng-Li Shi
Journal:  Virol Sin       Date:  2018-10-11       Impact factor: 4.327

4.  Risk Factors for MERS-CoV Seropositivity among Animal Market and Slaughterhouse Workers, Abu Dhabi, United Arab Emirates, 2014-2017.

Authors:  Ahmed Khudhair; Marie E Killerby; Mariam Al Mulla; Kheir Abou Elkheir; Wassim Ternanni; Zyad Bandar; Stefan Weber; Mary Khoury; George Donnelly; Salama Al Muhairi; Abdelmalik I Khalafalla; Suvang Trivedi; Azaibi Tamin; Natalie J Thornburg; John T Watson; Susan I Gerber; Farida Al Hosani; Aron J Hall
Journal:  Emerg Infect Dis       Date:  2019-05       Impact factor: 6.883

5.  Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.

Authors:  Nisreen M A Okba; V Stalin Raj; Ivy Widjaja; Corine H GeurtsvanKessel; Erwin de Bruin; Felicity D Chandler; Wan Beom Park; Nam-Joong Kim; Elmoubasher A B A Farag; Mohammed Al-Hajri; Berend-Jan Bosch; Myoung-Don Oh; Marion P G Koopmans; Chantal B E M Reusken; Bart L Haagmans
Journal:  Emerg Infect Dis       Date:  2019-10-17       Impact factor: 6.883

6.  Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.

Authors:  Marcel A Müller; Benjamin Meyer; Victor M Corman; Malak Al-Masri; Abdulhafeez Turkestani; Daniel Ritz; Andrea Sieberg; Souhaib Aldabbagh; Berend-J Bosch; Erik Lattwein; Raafat F Alhakeem; Abdullah M Assiri; Ali M Albarrak; Ali M Al-Shangiti; Jaffar A Al-Tawfiq; Paul Wikramaratna; Abdullah A Alrabeeah; Christian Drosten; Ziad A Memish
Journal:  Lancet Infect Dis       Date:  2015-04-08       Impact factor: 25.071

Review 7.  Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission.

Authors:  David S Hui; Esam I Azhar; Yae-Jean Kim; Ziad A Memish; Myoung-Don Oh; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2018-04-18       Impact factor: 25.071

Review 8.  Middle East respiratory syndrome (MERS) coronavirus and dromedaries.

Authors:  Ulrich Wernery; Susanna K P Lau; Patrick C Y Woo
Journal:  Vet J       Date:  2017-01-09       Impact factor: 2.688

Review 9.  Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

Authors:  M G Hemida; A Elmoslemany; F Al-Hizab; A Alnaeem; F Almathen; B Faye; D K W Chu; R A P M Perera; M Peiris
Journal:  Transbound Emerg Dis       Date:  2015-08-10       Impact factor: 5.005

10.  Reported Direct and Indirect Contact with Dromedary Camels among Laboratory-Confirmed MERS-CoV Cases.

Authors:  Romy Conzade; Rebecca Grant; Mamunur Rahman Malik; Amgad Elkholy; Mohamed Elhakim; Dalia Samhouri; Peter K Ben Embarek; Maria D Van Kerkhove
Journal:  Viruses       Date:  2018-08-13       Impact factor: 5.048

View more
  3 in total

Review 1.  Lessons for COVID-19 Immunity from Other Coronavirus Infections.

Authors:  Alan Sariol; Stanley Perlman
Journal:  Immunity       Date:  2020-07-14       Impact factor: 31.745

Review 2.  Unresolved questions in the zoonotic transmission of MERS.

Authors:  Malik Peiris; Stanley Perlman
Journal:  Curr Opin Virol       Date:  2022-01-06       Impact factor: 7.090

3.  High MERS-CoV seropositivity associated with camel herd profile, husbandry practices and household socio-demographic characteristics in Northern Kenya.

Authors:  I Ngere; P Munyua; J Harcourt; E Hunsperger; N Thornburg; M Muturi; E Osoro; J Gachohi; B Bodha; B Okotu; J Oyugi; W Jaoko; A Mwatondo; K Njenga; M A Widdowson
Journal:  Epidemiol Infect       Date:  2020-12-01       Impact factor: 4.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.